Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC vs IV Abatacept in RA with Inadequate Response to Methotrexate
NCT00559585Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2008
- Primary completion
- Nov 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 24
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Jan 2008; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00559585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559585.